Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.350
-0.005 (-1.44%)
At close: Nov 20, 2024, 4:00 PM
0.347
-0.003 (-0.83%)
Pre-market: Nov 21, 2024, 5:46 AM EST
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.12 million as of November 21, 2024. Its market cap has decreased by -19.97% in one year.
Market Cap
3.12M
Enterprise Value
9.40K
1-Year Change
-19.97%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since November 16, 2017, Enveric Biosciences's market cap has decreased from $137.90M to $3.12M, a decrease of -97.74%. That is a compound annual growth rate of -41.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.50M | 16.67% |
| Dec 29, 2023 | 3.00M | -30.23% |
| Dec 30, 2022 | 4.30M | -85.27% |
| Dec 31, 2021 | 29.20M | 265.00% |
| Dec 31, 2020 | 8.00M | 40.35% |
| Dec 31, 2019 | 5.70M | -17.39% |
| Dec 31, 2018 | 6.90M | -85.98% |
| Dec 29, 2017 | 49.20M | -64.32% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CareMax | 3.20M |
| Oncternal Therapeutics | 3.20M |
| NuCana | 3.19M |
| Aditxt | 3.15M |
| Palisade Bio | 3.12M |
| Matinas BioPharma Holdings | 2.98M |
| Aptorum Group | 2.95M |
| Quoin Pharmaceuticals | 2.93M |